INSPRA 25 mg clinical trials

A randomized crossover clinical trial regarding the blockage of the mineralocorticoid receptor using Eplerenone on the evolution of arterial stiffness in kidney patients one year after transplant: EVATRAN (The effect of Eplerenone on the evolution of Vasculopathy in renal transplant patients).

This study looks at how a drug called eplerenone affects the stiffness of blood vessels in kidney transplant patients. Researchers want to see if it can improve heart and blood vessel health a year after a kidney transplant.